ArticlePLOS global public health2025
"Now that I took TPT, it's affecting my ART adherence, viral load, even my wellbeing in the community". Exploring acceptability and experience of Tuberculosis Preventive Treatment among adolescents living with HIV in Zimbabwe.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis preventive treatment (TPT) is increasingly offered to people living with HIV in high-burden settings, including adolescents and young people (AYPLHIV). Evidence demonstrates that AYPLHIVs' HIV treatment engagement is improved by the provision of tailored support. How to effectively adapt this support to accommodate multimorbidity care, such as TPT alongside ART, warrants attention to deliver sustained optimal outcomes. We conducted qualitative research to better understand AYPLHIVs' experiences when initiating TPT and their related support needs. Peer counsellors (18-24 years) who were offered TPT within routine HIV care participated in two focus groups (n = 16 participants) and in-depth interviews (n = 12) in Harare. Iterative data collection and thematic analysis was conducted September 2023 to February 2024. TPT was presented by healthcare workers as uncomplicated and routine. This contrasted with participants' accounts of the significant disruptive and challenging experience of taking up TPT. This tension led many to stop TPT without support. Those who completed treatment were motivated by personal circumstances (e.g., recently witnessing severe TB illness, pregnancy); however, taking up and completing subsequent courses of TPT was not assured. TPT side effects and stigma led many to discontinue treatment, even when these were not personally experienced. Side effects recalled past experiences of HIV-stigma and discrimination, and undermined ART adherence, HIV viral suppression, and positive mental health. Introducing additional life-protecting treatments can have complicating biosocial effects, with consequences for individuals and public health. To support multimorbidity prevention and care, we outline five principles to guide initiating and maintaining treatment that acknowledges and responds to AYPLHIVs' dynamic immunological and social realities: Supported and safe relationships; Tailored messaging; Adaptable support; Respect for agency and autonomy; Timing: plan, review, revise (START). START emphasises investing in consistent peer support throughout adolescence, and centring AYPLHIVs' agency, embodied knowledge and wellbeing to ensure they are informed decision-makers about their health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.